Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Foundation Medicine, Inc. (FMI) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2018 CT ORDER Form CT ORDER - Confidential treatment order:
09/18/2018 10-Q/A Quarterly Report for the period ended June 30, 2018 [amend]
08/10/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
08/09/2018 10-Q Quarterly Report for the period ended June 30, 2018
08/03/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/03/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/03/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/03/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/03/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/02/2018 CT ORDER Form CT ORDER - Confidential treatment order:
07/31/2018 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of the Company (filed herewith)",
"Bylaws of the Company (filed herewith)"
07/31/2018 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
07/31/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
07/31/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/31/2018 SC 13D/A ROCHE HOLDING LTD reports a 100% stake in Foundation Medicine, Inc.
07/31/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/27/2018 GN New Research: Key Drivers of Growth for Cadence Design, Agenus, Foundation Medicine, Honeywell International, NeoPhotonics, and Citrix — Factors of Influence, Major Initiatives and Sustained Production
07/18/2018 10-Q/A Quarterly Report for the period ended March 31, 2018 [amend]
07/17/2018 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
07/17/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
07/17/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/02/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/02/2018 SC 13E3 Form SC 13E3 - Going private transaction by certain issuers:
07/02/2018 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
07/02/2018 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
06/21/2018 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : June 21, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commenceme..."
06/19/2018 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
06/19/2018 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
06/19/2018 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
06/19/2018 8-K Quarterly results
06/19/2018 SC 13D/A ROCHE HOLDING LTD reports a 56.6% stake in Foundation Medicine, Inc.
06/07/2018 8-K Entry into a Material Definitive Agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : June 6, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable"
05/22/2018 GN Analysis: Positioning to Benefit within Front Yard Residential, Foundation Medicine, SPX FLOW, Silicon Laboratories, John Wiley & Sons, and Hub Group — Research Highlights Growth, Revenue, and Consolidated Results
05/02/2018 10-Q Quarterly Report for the period ended March 31, 2018
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy